Blog

MFT for Biotech Companies: Why Your Next Breakthrough Shouldn’t Depend on an Email Attachment

Biotech research produces some of the most valuable data in the world: genomic sequences, protein structures, patient-derived cell data, assay outputs, and confidential partner submissions. Yet the way many small companies move that data has not kept pace with the science. Email attachments, ad hoc cloud links, USB drives, and one-off FTP scripts still appear …